A citation-based method for searching scientific literature

John M Dennis, Beverley M Shields, William E Henley, Angus G Jones, Andrew T Hattersley. Lancet Diabetes Endocrinol 2019
Times Cited: 88







List of co-cited articles
478 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables.
Emma Ahlqvist, Petter Storm, Annemari Käräjämäki, Mats Martinell, Mozhgan Dorkhan, Annelie Carlsson, Petter Vikman, Rashmi B Prasad, Dina Mansour Aly, Peter Almgren,[...]. Lancet Diabetes Endocrinol 2018
591
88

Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.
Oana P Zaharia, Klaus Strassburger, Alexander Strom, Gidon J Bönhof, Yanislava Karusheva, Sofia Antoniou, Kálmán Bódis, Daniel F Markgraf, Volker Burkart, Karsten Müssig,[...]. Lancet Diabetes Endocrinol 2019
103
52

Novel subgroups of patients with adult-onset diabetes in Chinese and US populations.
Xiantong Zou, Xianghai Zhou, Zhanxing Zhu, Linong Ji. Lancet Diabetes Endocrinol 2019
39
71

Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis.
Miriam S Udler, Jaegil Kim, Marcin von Grotthuss, Sílvia Bonàs-Guarch, Joanne B Cole, Joshua Chiou, Michael Boehnke, Markku Laakso, Gil Atzmon, Benjamin Glaser,[...]. PLoS Med 2018
131
30

Identification of type 2 diabetes subgroups through topological analysis of patient similarity.
Li Li, Wei-Yi Cheng, Benjamin S Glicksberg, Omri Gottesman, Ronald Tamler, Rong Chen, Erwin P Bottinger, Joel T Dudley. Sci Transl Med 2015
200
20


Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps.
Anubha Mahajan, Daniel Taliun, Matthias Thurner, Neil R Robertson, Jason M Torres, N William Rayner, Anthony J Payne, Valgerdur Steinthorsdottir, Robert A Scott, Niels Grarup,[...]. Nat Genet 2018
465
15

Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN-6 cardiovascular outcomes trials.
Anna R Kahkoska, Milan S Geybels, Klara R Klein, Frederik F Kreiner, Nikolaus Marx, Michael A Nauck, Richard E Pratley, Benjamin O Wolthers, John B Buse. Diabetes Obes Metab 2020
16
87


Stratification of type 2 diabetes based on routine clinical markers.
Narges Safai, Ashfaq Ali, Peter Rossing, Martin Ridderstråle. Diabetes Res Clin Pract 2018
20
55

Factors Associated with Risk of Diabetic Complications in Novel Cluster-Based Diabetes Subgroups: A Japanese Retrospective Cohort Study.
Hayato Tanabe, Haruka Saito, Akihiro Kudo, Noritaka Machii, Hiroyuki Hirai, Gulinu Maimaituxun, Kenichi Tanaka, Hiroaki Masuzaki, Tsuyoshi Watanabe, Koichi Asahi,[...]. J Clin Med 2020
13
84

Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes.
Anubha Mahajan, Jennifer Wessel, Sara M Willems, Wei Zhao, Neil R Robertson, Audrey Y Chu, Wei Gan, Hidetoshi Kitajima, Daniel Taliun, N William Rayner,[...]. Nat Genet 2018
152
11

Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study.
Ranjit Mohan Anjana, Viswanathan Baskar, Anand Thakarakkattil Narayanan Nair, Saravanan Jebarani, Moneeza Kalhan Siddiqui, Rajendra Pradeepa, Ranjit Unnikrishnan, Colin Palmer, Ewan Pearson, Viswanathan Mohan. BMJ Open Diabetes Res Care 2020
19
52

Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine.
Miriam S Udler, Mark I McCarthy, Jose C Florez, Anubha Mahajan. Endocr Rev 2019
53
16

Type 2 diabetes: a multifaceted disease.
Ewan R Pearson. Diabetologia 2019
34
26

The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema.
Stanley S Schwartz, Solomon Epstein, Barbara E Corkey, Struan F A Grant, James R Gavin, Richard B Aguilar. Diabetes Care 2016
133
9

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
9

Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis.
Keiichi Kodama, Damon Tojjar, Satoru Yamada, Kyoko Toda, Chirag J Patel, Atul J Butte. Diabetes Care 2013
297
9

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
9


Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank.
Nicholas J Thomas, Samuel E Jones, Michael N Weedon, Beverley M Shields, Richard A Oram, Andrew T Hattersley. Lancet Diabetes Endocrinol 2018
155
7

Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
Ewan R Pearson, Isabelle Flechtner, Pål R Njølstad, Maciej T Malecki, Sarah E Flanagan, Brian Larkin, Frances M Ashcroft, Iwar Klimes, Ethel Codner, Violeta Iotova,[...]. N Engl J Med 2006
627
7

Precision diabetes: learning from monogenic diabetes.
Andrew T Hattersley, Kashyap A Patel. Diabetologia 2017
115
7

A Global Overview of Precision Medicine in Type 2 Diabetes.
Hugo Fitipaldi, Mark I McCarthy, Jose C Florez, Paul W Franks. Diabetes 2018
34
20

The many faces of diabetes: a disease with increasing heterogeneity.
Tiinamaija Tuomi, Nicola Santoro, Sonia Caprio, Mengyin Cai, Jianping Weng, Leif Groop. Lancet 2014
306
7


Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetes Care 2018
7


Genetic cause of hyperglycaemia and response to treatment in diabetes.
Ewan R Pearson, Bryan J Starkey, Roy J Powell, Fiona M Gribble, Penny M Clark, Andrew T Hattersley. Lancet 2003
335
6

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.
Amit V Khera, Mark Chaffin, Krishna G Aragam, Mary E Haas, Carolina Roselli, Seung Hoan Choi, Pradeep Natarajan, Eric S Lander, Steven A Lubitz, Patrick T Ellinor,[...]. Nat Genet 2018
817
6

Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetologia 2018
528
6

Precision medicine in the management of type 2 diabetes.
Anna L Gloyn, Daniel J Drucker. Lancet Diabetes Endocrinol 2018
36
16

Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.
Adam G Tabák, Markus Jokela, Tasnime N Akbaraly, Eric J Brunner, Mika Kivimäki, Daniel R Witte. Lancet 2009
486
6

Maturity-onset diabetes of the young (MODY): how many cases are we missing?
B M Shields, S Hicks, M H Shepherd, K Colclough, A T Hattersley, S Ellard. Diabetologia 2010
343
5

An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans.
Robert A Scott, Laura J Scott, Reedik Mägi, Letizia Marullo, Kyle J Gaulton, Marika Kaakinen, Natalia Pervjakova, Tune H Pers, Andrew D Johnson, John D Eicher,[...]. Diabetes 2017
311
5

Clinical risk factors, DNA variants, and the development of type 2 diabetes.
Valeriya Lyssenko, Anna Jonsson, Peter Almgren, Nicoló Pulizzi, Bo Isomaa, Tiinamaija Tuomi, Göran Berglund, David Altshuler, Peter Nilsson, Leif Groop. N Engl J Med 2008
577
5

Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls.
Jason Flannick, Josep M Mercader, Christian Fuchsberger, Miriam S Udler, Anubha Mahajan, Jennifer Wessel, Tanya M Teslovich, Lizz Caulkins, Ryan Koesterer, Francisco Barajas-Olmos,[...]. Nature 2019
99
5

Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program.
Marie-France Hivert, Kathleen A Jablonski, Leigh Perreault, Richa Saxena, Jarred B McAteer, Paul W Franks, Richard F Hamman, Steven E Kahn, Steven Haffner, James B Meigs,[...]. Diabetes 2011
123
5

Glucotypes reveal new patterns of glucose dysregulation.
Heather Hall, Dalia Perelman, Alessandra Breschi, Patricia Limcaoco, Ryan Kellogg, Tracey McLaughlin, Michael Snyder. PLoS Biol 2018
70
7

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
5

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
5

The integrative biology of type 2 diabetes.
Michael Roden, Gerald I Shulman. Nature 2019
173
5

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
Francesco Cosentino, Peter J Grant, Victor Aboyans, Clifford J Bailey, Antonio Ceriello, Victoria Delgado, Massimo Federici, Gerasimos Filippatos, Diederick E Grobbee, Tina Birgitte Hansen,[...]. Eur Heart J 2020
974
5


Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes.
Robert Wagner, Martin Heni, Adam G Tabák, Jürgen Machann, Fritz Schick, Elko Randrianarisoa, Martin Hrabě de Angelis, Andreas L Birkenfeld, Norbert Stefan, Andreas Peter,[...]. Nat Med 2021
25
20

Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach.
Omar Yaxmehen Bello-Chavolla, Jessica Paola Bahena-López, Arsenio Vargas-Vázquez, Neftali Eduardo Antonio-Villa, Alejandro Márquez-Salinas, Carlos A Fermín-Martínez, Rosalba Rojas, Roopa Mehta, Ivette Cruz-Bautista, Sergio Hernández-Jiménez,[...]. BMJ Open Diabetes Res Care 2020
7
71

Subtypes of Type 2 Diabetes Determined From Clinical Parameters.
Emma Ahlqvist, Rashmi B Prasad, Leif Groop. Diabetes 2020
16
31

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
Steven E Kahn, Steven M Haffner, Mark A Heise, William H Herman, Rury R Holman, Nigel P Jones, Barbara G Kravitz, John M Lachin, M Colleen O'Neill, Bernard Zinman,[...]. N Engl J Med 2006
4

The genetic architecture of type 2 diabetes.
Christian Fuchsberger, Jason Flannick, Tanya M Teslovich, Anubha Mahajan, Vineeta Agarwala, Kyle J Gaulton, Clement Ma, Pierre Fontanillas, Loukas Moutsianas, Davis J McCarthy,[...]. Nature 2016
569
4

A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults.
Richard A Oram, Kashyap Patel, Anita Hill, Beverley Shields, Timothy J McDonald, Angus Jones, Andrew T Hattersley, Michael N Weedon. Diabetes Care 2016
128
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.